Skip to main content
logo
Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
3.680
-0.020 (-0.54%)
Sep 4, 2026, 10:31 AM EDT - Market open

Liminatus Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-12.52-10.21-3.55-4.98-2.93-5.61
Depreciation & Amortization
00---0
Asset Writedown & Restructuring Costs
----0.90.9
Other Operating Activities
8.527.23---1.5
Change in Accounts Payable
-2.29-4.04-0.010.430.090.04
Change in Other Net Operating Assets
2.32-2.952.111.211.073.01
Operating Cash Flow
-3.97-9.96-1.45-3.35-0.87-0.17
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.01----
Investing Cash Flow
-0.01-0.79-2.85-0.82--

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-4.343.923.419.44-
Total Debt Issued
-4.343.923.419.44-
Short-Term Debt Repaid
--1.3--3.86-7.03-
Total Debt Repaid
-1.3-1.3--3.86-7.03-
Net Debt Issued (Repaid)
-1.33.043.92-0.452.42-
Issuance of Common Stock
3.810.56--4.2-
Repurchase of Common Stock
-----0.7-
Other Financing Activities
3.16-2.56----
Financing Cash Flow
5.6611.033.92-0.455.92-

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1.680.28-0.38-4.615.05-0.17

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.99-9.98-1.45-3.35-0.87-0.17
Free Cash Flow Growth
------
Free Cash Flow Per Share
-5.75-21.00-4.15-1.63-1.22-
Levered Free Cash Flow
-10.017.14-2.92-2.3-0.67-
Unlevered Free Cash Flow
-9.967.28-2.71-2.19-0.53-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
----0.5-
Change in Working Capital
0.03-6.982.11.641.163.05
SEC Filings: 10-K · 10-Q